MYD88 and osteomyelitis: Putman et al., 2019, demonstrated that MyD88 and IL-1R signaling are necessary for efficient antibacterial immune responses during osteomyelitis but, on the other hand, may also promote osteoclastogenesis and host-mediated bone loss during osteomyelitis [95].